Webinar: Lactose and lactose intolerance

This webinar has ended. You can watch the recording here.

Question: At what age is the activity of the lactase enzyme generally lost?*

A.  directly after weaning
B.  this is variable between racial groups
C.  before the age of 6 year
*See the answer(s) at the end of the page. Multiple answers possible.

Live webinar

When?                    27 June 2019 | 2pm (UK); 3pm (NL, BE); 8pm (ID, VN); 9pm (CN, HK, MY, SG, PH)
For who?               Nutrition and health professionals
Costs?                    This webinar is provided free of charge by FrieslandCampina Institute
Language?           English
Accreditation?   Accredited by ADAP (Dutch dietitians) and the Singapore Nutrition and Dietetics Association (SNDA) with 1 point

What will you learn?

• Overview on the enzyme lactase
  – Working, regulation, lactase persistence (LP) and lactase non-persistence (LNP)
  – The difference between LP, LNP, lactase deficiency (LD), lactose maldigestion (LM), lactose intolerance (LI), self-reported LI (SRLI) and lactose sensitivity (LS) in adults as well as congenital LI and neonatal LI
• Epidemiology, diagnosis and management of lactose intolerance
  – Pathophysiology and prevalence worldwide
  – Complexities within lactose intolerance

The webinar will last for 60 minutes. If you already have questions now, you can write in the registration form and the speaker will address them during the webinar.

After you’ve signed up, we will send you a link via email on 24th and 27th June, which you can use to join the webinar.

About the speaker

Dr Jan Geurts is an expert on dairy nutrition, general health and metabolic health. He has authored and co-authored more than 100 journal and conference papers to date. Currently, Dr Geurts works as a principal scientist in the Nutritional Sciences Department of FrieslandCampina. Previously, he was assistant professor in the Department of Molecular Cell Biology at the University of Maastricht, where he was involved in clinical and nutritional research for the CARIM and NUTRIM Research Institutes, respectively. Between 1995 and 1997, he worked as a postdoctoral scholar, employed by the Flemish Institute for Biotechnology, on the topic of cancer biology. Dr Geurts holds a M.Sc. degree (cum laude) in biology from the Radboud University, Nijmegen, the Netherlands and a Ph.D. degree in human genetics from the University of Leuven, Belgium.

*Answer to the question above: Both B and C are correct!